Droksikam

Droksikam
Klinički podaci
AHFS/Drugs.com	Monografija
Identifikatori
ATC kod	M01AC04
PubChem	65679
UNII	F24ADO1E2D
KEGG	D07267
Hemijski podaci
Formula	C16H11N3O5S
Mol. masa	357,341
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C16H11N3O5S/c1-18-13-14(10-6-2-3-7-11(10)25(18,22)23)24-16(21)19(15(13)20)12-8-4-5-9-17-12/h2-9H,1H3; Key: OEHFRZLKGRKFAS-UHFFFAOYSA-N
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

Droksikam je organsko jedinjenje, koje sadrži 16 atoma ugljenika i ima molekulsku masu od 357,341 Da.

Osobine

Osobina	Vrednost
Broj akceptora vodonika	6
Broj donora vodonika	0
Broj rotacionih veza	1
Particioni koeficijent^[4] (ALogP)	1,1
Rastvorljivost^[5] (logS, log(mol/L))	-3,4
Polarna površina^[6] (PSA, Å²)	105,3

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
↑ Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o.
↑ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573.
↑ Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286.

Literatura

Hardman JG, Limbird LE, Gilman AG. (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10 izd.). New York: McGraw-Hill. DOI:10.1036/0071422803. ISBN 0-07-135469-7.
Thomas L. Lemke, David A. Williams, ur. (2007). Foye's Principles of Medicinal Chemistry (6 izd.). Baltimore: Lippincott Willams & Wilkins. ISBN 0-7817-6879-9.

Vanjske veze

	Portal Medicina
	Portal Hemija

Droxicam

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.

[4] Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o.

[5] Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573.

[6] Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286.

[1]

[2]

[3]

[4]

[5]

[6]

p r u Nesteroidni antiinflamatorni lek (NSAIL) (M01A i M02A, N02BA)
Salicilati	Aspirin (acetilsalicilna kiselina) • Aloksiprin • Benorilat • Diflunisal • Etenzamid • Magnezijum salicilat • Metil salicilat • Salsalat • Salicin • Salicilamid • Natrijum salicilat
Arilalkanoinske kiseline	Diklofenak • Aceklofenak • Acemetacin • Alklofenak • Bromfenak • Etodolak • Indometacin • Indometacin farnesil • Nabumeton • Oksametacin • Proglumetacin • Sulindac • Tolmetin
2-Arilpropionske kiseline (profeni)	Ibuprofen • Alminoprofen • Benoksaprofen • Karprofen • Deksibuprofen • Deksketoprofen • Fenbufen • Fenoprofen • Flunoksaprofen • Flurbiprofen • Ibuproksam • Indoprofen^† • Ketoprofen • Ketorolak • Loksoprofen • Miroprofen • Naproksen • Oksaprozin • Pirprofen • Suprofen • Tarenflurbil • Tiaprofenska kiselina
N-Arilantranilne kiseline (fenaminske kiseline)	Mefenamska kiselina • Flufenaminska kiselina • Meklofenaminska kiselina • Tolfenaminska kiselina
Pirazolidinski derivativi	Fenilbutazon • Ampiron • Azapropazon • Klofezon • Kebuzon • Metamizol • Mofebutazon • Oksifenbutazon • Fenazon • Sulfinpirazon
Oksikami	Piroksikam • Droksikam • Lornoksikam • Meloksikam • Tenoksikam • Ampiroksikam
COX -2 inhibitori	Celekoksib • Derakoksib^‡ • Etorikoksib • Firokoksib^‡ • Lumirakoksib^† • Parekoksib • Rofekoksib^† • Valdekoksib^†
Sulfonanilidi	Nimesulid
Proizvodi sa topičkom primenom	Bendazac • Diklofenak • Etofenamat • Felbinak • Flurbiprofen • Ibuprofen • Indometacin • Ketoprofen • Naproksen • Piroksikam • Suprofen
COX-inhibirajući donori azot oksida	Naprokscinod
Drugi	Fluprohazon
Podebljani nazivi označavaju jedinjenja (spojeve) inicijalno razvijene u specifičnim grupama. ^†Lekovi povučeni sa tržišta. ^‡Veterinarski lekovi.